Death rates weren't reduced by transfusing survivors' plasma into Ebola patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
van Griensven, J. et al. N. Engl. J. Med. 374, 33–42 (2016).
Additional information
Related links
Related links
Related links in Nature Research
How to beat the next Ebola 2015-Aug-05
Ebola raises profile of blood-based therapy 2014-Dec-23
First trials of blood-based Ebola therapy kick off 2014-Dec-15
Blood transfusion named as priority treatment for Ebola 2014-Sep-05
Nature Special: the Ebola epidemic
Related external links
Rights and permissions
About this article
Cite this article
Butler, D. Trial of blood-based Ebola therapy disappoints. Nature (2016). https://doi.org/10.1038/nature.2016.19125
Published:
DOI: https://doi.org/10.1038/nature.2016.19125
